Feed aggregator

How to Nail Your First Biopharma Interview After College

Biospace news - Thu, 06/10/2021 - 02:00
The first biopharma interview after college will increase your stress and anxiety. However, we offer a few time-tested tips to help you nail your first interview.

FDA grants accelerated approval for Alzheimer's drug

World Pharma News - Wed, 06/09/2021 - 12:00
The U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.

Valneva completes Phase 3 trial recruitment for its inactivated COVID-19 vaccine candidate

World Pharma News - Wed, 06/09/2021 - 10:00
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced that it has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.

FDA Signs Off on Pfizer's Pneumococcal 20-Valent Conjugate Vaccine in Adults

Biospace news - Wed, 06/09/2021 - 02:00
Pfizer says it expects the U.S. CDC's ACI to meet in October to recommend the appropriate and safe use of pneumococcal vaccines, including PREVNAR 20, in adults.

Data Companies Merge to Create Nation’s Largest Health Care Data Ecosystem

Biospace news - Wed, 06/09/2021 - 02:00
The $7 billion transaction by Datavant with Ciox Health will be the nation's largest "neutral and secure health data ecosystem."

Bharat Biotech Plans Phase IV Study of Covaxin While Ocugen Eyes US EUA

Biospace news - Wed, 06/09/2021 - 02:00
Bharat will conduct Phase IV studies to check real-world efficacy against the virus, while Ocugen says Covaxin will be a valuable tool in helping to end the COVID-19 pandemic.

A Recent Flurry Of Biotech IPOs: Lyell, Atai, Alzamend and More

Biospace news - Wed, 06/09/2021 - 02:00
The last few weeks have seen a flurry of filings for initial public offerings by biotech companies. Here’s a look.

Kojin Therapeutics Debuts to Solve Difficult Diseases Through Cell Behavior

Biospace news - Wed, 06/09/2021 - 02:00
Kojin launched with a $60 million Series A to focus on oncology and cell state biology led by Polaris Partners, Newpath Partners and Cathay Health.

Genentech’s Dr. Charles Fuchs: “The Era of Personalized Cancer Care is Here”

Biospace news - Wed, 06/09/2021 - 02:00
BioSpace caught up with Charles Fuchs, M.D., SVP, Global Head of Oncology & Hematology Product Development, Genentech during the ASCO meeting.

Money on the Move: June 2-8

Biospace news - Wed, 06/09/2021 - 02:00
Things are warming up quickly this summer for life sciences investors. Here’s who’s coming in hot with cash this week.

Some People May Have a Gene Variant that Protects Against COVID-19

Biospace news - Wed, 06/09/2021 - 02:00
Newcastle University researchers identified a gene, HLA-DRB1*04:01, which was three times more common in asymptomatic COVID-19 patients than in people with symptomatic disease.

Biogen CEO Announces Rollout Plan for Newly Approved Alzheimer's Drug

Biospace news - Wed, 06/09/2021 - 02:00
In a conference call on Wednesday, Biogen CEO Michel Vounatsos outlined the company's plans for commercial distribution of Aduhelm.

Flagship’s Valo Health Joins SPAC Craze and Lists on Nasdaq

Biospace news - Wed, 06/09/2021 - 02:00
Valo Health is the latest company to go public through a merger with a special purpose acquisition company. It will merge with Khosla Ventures Acquisition Co. and begin to trade on the Nasdaq.

Let’s Get to Know Mir Imran, CEO and Chief Innovator at Rani Therapeutics

Biospace news - Wed, 06/09/2021 - 02:00
BioSpace recently spoke with Mir Imran, CEO and Chief Innovator at Rani Therapeutics, a company developing and testing a “robotic” pill that delivers biologics orally.

AbbVie Partners With Caraway to Develop Parkinson’s Disease Therapeutics

Biospace news - Wed, 06/09/2021 - 02:00
The collaboration agreement will see the development and commercialization of the target, TMEM175 involved in Parkinson's disease and other neurodegenerative conditions.

How to Write an Effective Pharmaceutical Job Description with Sample

Biospace news - Wed, 06/09/2021 - 02:00
Like in writing any job description, composing one for a pharmaceutical job offering must contain all the information a candidate must know.

CDC COVID-19 study shows mRNA vaccines reduce risk of infection by 91 percent for fully vaccinated people

World Pharma News - Tue, 06/08/2021 - 18:51
A new CDC study finds the mRNA COVID-19 vaccines authorized by the Food and Drug Administration (Pfizer-BioNTech and Moderna) reduce the risk of infection by 91 percent for fully vaccinated people. This adds to the growing body of real-world evidence of their effectiveness. Importantly, this study also is among the first to show that mRNA vaccination benefits people who get COVID-19 despite being fully vaccinated

Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson's disease

World Pharma News - Tue, 06/08/2021 - 10:00
Bayer AG announced today that BlueRock Therapeutics (BlueRock), a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, successfully administered the first dose of its pluripotent stem cell-derived dopaminergic neurons, named DA01, to a Parkinson's disease patient in their open-label Phase 1 clinical study.

Byondis' ADC Candidate Shows Prolonged PFS in HER-2+ Advanced Breast Cancer

Biospace news - Tue, 06/08/2021 - 02:00
Results from the Phase III TULIP® study show an antibody-drug conjugate from Byondis significantly prolonged PFS in patients with pretreated HER2-positive metastatic breast cancer.

Will the H10N3 Avian Flu Strain, Now in Humans, Become the Next Pandemic?

Biospace news - Tue, 06/08/2021 - 02:00
The first human case of a new strain of avian flu was diagnosed in China in late May. Chinese health authorities say there is a low risk of contagion. After China notoriously underreported COVID-19 mortality, can this new assurance be trusted?